| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |